Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BIO Integration is Scopus-indexed (Q1, CiteScore 4.8), DOAJ. Published by Compuscript Ltd.
Checked against the index lists dated .
ISSN 2712-0082Verify ISSN ↗
Publisher: Compuscript Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 101 / 669 | 84th | Q1 |
| Biochemistry, Genetics and Molecular Biology (miscellaneous) | 42 / 144 | 71st | Q2 |
| Biophysics | 64 / 155 | 59th | Q2 |
| Biotechnology | 151 / 325 | 53rd | Q2 |
| Biomedical Engineering | 159 / 342 | 53rd | Q2 |
| Biochemistry | 229 / 448 | 48th | Q3 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q1, CiteScore 4.8.
BIO Integration is Q1 in Medicine (all) (rank 101 of 669), Q2 in Biochemistry, Genetics and Molecular Biology (miscellaneous) (rank 42 of 144) and Q2 in Biophysics (rank 64 of 155), by CiteScore 2025. It is ranked in 6 subject areas in all.
BIO Integration is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 4.8, quartile Q1, 84th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.859, quartile Q1, with an H-index of 18.
BIO Integration is published by Compuscript Ltd. Its ISSN is 2712-0082.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
BIO Integration has an h-index of 23 and a 2-year mean of 5.93 citations per paper (OpenAlex). Its Scopus CiteScore is 4.8, quartile Q1. On 2-year citations it ranks #32 of 646 Scopus journals in Medicine (all).
BIO Integration published 37 papers in 2025; its busiest recent year was 2024 with 39. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 67 research articles (2024–2026), authors are most often from China (41.6%), India (16.9%) and United States (12.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.